BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.8.15//EN
X-ORIGINAL-URL:https://stage.utoronto.ca/
X-WR-CALNAME:CANSSI Ontario STAGE
X-WR-CALDESC:
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-532a082cc38eaffa923d73bce41b4061@stage.utoronto.ca
DTSTART:20130111T170000Z
DTEND:20130111T180000Z
DTSTAMP:20250718T233700Z
CREATED:20250718
LAST-MODIFIED:20260316
PRIORITY:5
SEQUENCE:156
TRANSP:OPAQUE
SUMMARY:STAGE ISSS: David  Trégouët
DESCRIPTION:\nJoin us for the next instalment of the STAGE International Speaker Seminar Series (ISSS) with\n\n\n\nDavid Trégouët\n\n\n\nResearch Director, UMR_S 937Genomics of Venous Thrombosis UnitInstitut National de la Recherche Médicale (INSERM), France\n\n\n\nTalk Title:\n\n\n\nHaplotypes & Imputation, Two Complementary Tools: A Case Study on Genome-Wide Expression Studies \n\n\n\nAbstract:\n\n\n\nThe development of high throughput technologies has stimulated comprehensive surveys on genome-wide expression and DNA variability data for disentangling the genetic architecture of human diseases. The genetics of transcript abundance has been extensively investigated through genome-wide expression studies (GWES). These studies demonstrated that, for a large fraction of genes (so-called eQTLs), expression is influenced by single nucleotide polymorphisms (SNPs) located in the vicinity of the regulated genes, generally referred to as cis eSNPs. The importance of cis eSNPs would be enhanced if they were associated at the same time with a disease, as such data would indicate that the associated gene is a candidate for the disease. Most cis eQTL studies so far were based on single SNP analyses that did not account for the multiplicity of cis eSNPs that are often observed at an eQTL. One way to investigate whether associations observed at several cis eSNPs of the same eQTL are independent, or due to linkage disequilibrium (LD) between SNPs, is to conduct haplotype analysis, a strategy known to be able to distinguish “true” effect from those due to LD. Another approach is to perform GWES conditioning on the best cis eSNPs identified through a first run of GWES. The limitation of this strategy is that it is only able to identify cis eSNPs that have independent additive effects, contrary to haplotype analysis which can identify combinations of SNPs having non-additive effects or tagging a rare functional variant. In this work, we conducted a systematic genome-wide search for haplotypic cis-acting effects on monocyte gene expression using data from the Cardiogenics Transcriptomic Study and replicate the main findings in the Gutenberg Healthy Study. Replicated findings were completed by 1000Genome based imputation analysis. We identified 105 genes whose monocyte expression was under the influence of multiple cis-acting SNPs. About 75% of the detected genetic effects were related to independent additive SNP effects and the last quarter due to more complex haplotype effects. Of note, twenty-four of the genes identified to be affected by multiple cis eSNPs have been previously reported to reside at disease-associated loci. This could suggest that such multiple locusspecific genetic effects could contribute to the susceptibility to human diseases.\n\n\n\nSpeaker Profile:\n\n\n\nDavid-Alexandre Trégouët was recruited at INSERM as a research associate in 1999 just after completing his PhD in statistical genetics. Since then, he has been working at INSERM UMR_S 937, a research department led by Francois Cambien, and focusing on cardiovascular genomics. In December 2009, he was promoted to lead the team “Genomics of Venous Thrombosis” within INSERM UMR_S 937. In 2011, he was named director of the Genomics department of the Institute for Cardiometabolism and Nutrition and coordinator of the biostatistis/bioinformatics group of the post-genomics platform at the Pitié-Salpêtrière Hospital. David-Alexandre Trégouët is recognized for his expertise in the analysis of genetic association studies and the development of statistical tools for the analysis of highthroughput microarray data as part of genome-wide association and expression studies (GWAS/GWES). He conducted the first two GWAS on venous thrombosis and developed tools for genome-wide haplotype association analysis. \n\n\n\nSpeaker Poster:\n\n\n\n\n\n\n\nDavid Trégouët Poster ( https://stage.utoronto.ca/wp-content/uploads/2025/07/Tregouet-David-Poster.pdf )Download\n\n\n\nPhotography Disclosure:\n\n\n\nPhotographs and/or video may be taken of participants at STAGE events. These photos/videos are for the Program’s use only and may appear on its website, in printed brochures, or in other promotional or reporting materials. By attending STAGE events, you accept the possibility that you may be videotaped or photographed. If you have any concerns, please inform us by sending an e-mail to esther.berzunza@utoronto.ca\n
URL:https://stage.utoronto.ca/events/stage-isss-david-tregouet/
ORGANIZER;CN=CANSSI Ontario:MAILTO:esther.berzunza@utoronto.ca
CATEGORIES:CANSSI Ontario STAGE ISSS
LOCATION:4th Floor, Elm Wing, 555 University Ave, Toronto, ON
ATTACH;FMTTYPE=image/png:https://stage.utoronto.ca/wp-content/uploads/2025/07/Tregouet-David.png
END:VEVENT
END:VCALENDAR